A Multicenter Clinical Study of rTMS for Parkinson's Disease
NCT ID: NCT06009471
Last Updated: 2023-08-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
200 participants
INTERVENTIONAL
2023-07-01
2025-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Efficacy of Repetitive Transcranial Magnetic Stimulation in Parkinson's Disease:A Randomized, Double-blind, Multicenter, Placebo-controlled Trial
NCT06583278
Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment for Parkinson Disease
NCT02969941
Repetitive Transcranial Magnetic Stimulation for Musculoskeletal Pain in Patients With Parkinson's Disease
NCT05537597
Navigated Repetitive Transcranial Magnetic Stimulation for Parkinson's Disease With Depression or Cognitive Impairment
NCT04707378
The Efficacy and Safety of Precision REpetitive Transcranial Magnetic Stimulation in Alleviating Motor Symptom in Parkinson's Disease
NCT06383247
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
All participants were treated with routine treatment in Neurology.
Routine treatment in Neurology
Routine treatment in Neurology department, including drug treatment,etc.
Experimental group
All participants were treated with routine treatment in Neurology and rTMS treatment.
rTMS parameters were set to stimulate the site: bilateral primary motor cortex; Stimulus frequency :5Hz; Pulse number: 1000 pulses per day, 500 on the left and 500 on the right; Stimulus intensity :90% resting threshold; Coil: 70mm round coil; Once a day, 30 minutes each time, 5 days a week for 4 weeks
Routine treatment in Neurology and rTMS
Add rTMS to routine treatment. Low frequency rTMS is often used to treat cortical hyperexcitability and high frequency rTMS to treat hypoexcitability
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Routine treatment in Neurology
Routine treatment in Neurology department, including drug treatment,etc.
Routine treatment in Neurology and rTMS
Add rTMS to routine treatment. Low frequency rTMS is often used to treat cortical hyperexcitability and high frequency rTMS to treat hypoexcitability
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have a primary school education or above and can read the scale used in this study;
* MoCA score between 20 and 24, mild cognitive impairment ;
* Aged between 30 and 80, regardless of gender;
* Voluntarily participate and sign informed consent.
Exclusion Criteria
* patients with serious mental disorders and cognitive disorders who cannot cooperate with assessment;
* patients with severe liver, kidney, heart dysfunction and severe physical disorders;
* Implanted devices such as pacemakers are installed inside the body;
* drug-induced Parkinson's syndrome or Parkinson's superposition syndrome;
* Have a history of epilepsy;
* Women during pregnancy and breastfeeding.
30 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Affiliated Hospital of Nantong University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
rTMS
Nantong, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LCYJ-B06
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.